Grandfield & Dodd Portfolio holdings
Grandfield & Dodd is an independently owned investment counsel firm that builds portfolios of individual stocks and bonds for individuals, families and trusts. Cheryl Grandfield, a former partner at Brundage, Story & Rose, started it in 2001 with Richard Dodd, who had been a senior portfolio manager of tax-exempt bonds at The Bank of New York, and James Samuels. They saw a gap as investment managers moved toward standardised pooled products, and aimed at clients who preferred owning individual securities directly. On stocks, the firm looks at companies as a business owner would and favours industry leaders, while keeping its holdings spread across industries and securities. Its bond holdings lean toward higher quality and shorter maturities, which limits how far prices swing when interest rates change.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$4.72M |
| 2 |
A.O. Smith
AOS
|
+$2.6M |
| 3 |
Carlisle Companies
CSL
|
+$2.36M |
| 4 |
Veralto
VLTO
|
+$1.71M |
| 5 |
Autodesk
ADSK
|
+$1.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$3.25M |
| 2 |
Diageo
DEO
|
+$2.8M |
| 3 |
Johnson Controls International
JCI
|
+$2.66M |
| 4 |
GE Aerospace
GE
|
+$1.62M |
| 5 |
Analog Devices
ADI
|
+$1.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.78% |
| 2 | Industrials | 19.46% |
| 3 | Healthcare | 14.71% |
| 4 | Financials | 8.44% |
| 5 | Materials | 7.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Chevron
CVX
$415B
| $23.8M | 1.27% |
116,426
-243
| -0.2% | -$47.8K |
2013 Q2
53 quarters
|
|
27
Walt Disney
DIS
$202B
| $23.7M | 1.26% |
225,814
+2,409
| +1% | +$247K |
2013 Q2
53 quarters
|
|
28
Shell
SHEL
$284B
| $23.3M | 1.24% |
244,727
-747
| -0.3% | -$67.4K |
2022 Q1
18 quarters
|
|
29
Gilead Sciences
GILD
$208B
| $22.8M | 1.22% |
152,837
-1,450
| -0.9% | -$203K |
2013 Q2
53 quarters
|
|
30
Trimble
TRMB
$12.3B
| $22.8M | 1.21% |
398,551
+7,584
| +2% | +$431K |
2015 Q2
45 quarters
|
|
31
GE HealthCare
GEHC
$37.9B
| $21.9M | 1.17% |
335,368
-1,876
| -0.6% | -$127K |
2023 Q1
14 quarters
|
|
32
Novartis
NVS
$306B
| $21.9M | 1.17% |
153,313
-123
| -0.1% | -$18.7K |
2013 Q2
53 quarters
|
|
33
Mettler-Toledo International
MTD
$33.6B
| $21.4M | 1.14% |
14,149
+413
| +3% | +$570K |
2021 Q3
20 quarters
|
|
34
Unilever
UL
$146B
| $20.4M | 1.09% |
335,587
+2,112
| +0.6% | +$133K |
2013 Q2
53 quarters
|
|
35
Hormel Foods
HRL
$12.4B
| $19.8M | 1.06% |
995,031
-10,871
| -1% | -$253K |
2013 Q2
53 quarters
|
|
36
PayPal
PYPL
$49B
| $19.3M | 1.03% |
367,656
-15,391
| -4% | -$847K |
2015 Q3
44 quarters
|
|
37
Rockwell Automation
ROK
$42.3B
| $18.4M | 0.98% |
42,298
-738
| -2% | -$328K |
2024 Q1
10 quarters
|
|
|
38
Boeing
BA
$137B
| $17.4M | 0.93% |
93,327
+22,015
| +31% | +$4.72M |
2015 Q2
45 quarters
|
|
39
Procter & Gamble
PG
$387B
| $17.3M | 0.92% |
119,359
-687
| -0.6% | -$101K |
2013 Q2
53 quarters
|
|
40
PPG Industries
PPG
$27.2B
| $16.9M | 0.9% |
162,171
+4,087
| +3% | +$462K |
2013 Q2
53 quarters
|
|
41
ExxonMobil
XOM
$674B
| $16.7M | 0.89% |
102,762
-169
| -0.2% | -$26.4K |
2013 Q2
53 quarters
|
|
42
Devon Energy
DVN
$47.2B
| $16.4M | 0.88% |
356,690
+2,580
| +0.7% | +$118K |
2013 Q2
53 quarters
|
|
43
Sanofi
SNY
$112B
| $15.9M | 0.85% |
385,082
+439
| +0.1% | +$19.1K |
2016 Q2
41 quarters
|
|
44
AutoZone
AZO
$53.3B
| $14.8M | 0.79% |
5,222
+229
| +5% | +$684K |
2021 Q3
20 quarters
|
|
|
45
A.O. Smith
AOS
$8.94B
| $14.3M | 0.76% |
253,455
+43,125
| +21% | +$2.6M |
2025 Q4
3 quarters
|
|
46
Vertex Pharmaceuticals
VRTX
$138B
| $13.4M | 0.72% |
25,689
+851
| +3% | +$436K |
2014 Q2
49 quarters
|
|
47
Thermo Fisher Scientific
TMO
$251B
| $13M | 0.69% |
19,224
-130
| -0.7% | -$77.2K |
2013 Q2
53 quarters
|
|
48
Berkshire Hathaway Class A
BRK.A
$1.22T
| $12.7M | 0.68% |
17
| – | – |
2013 Q2
53 quarters
|
|
49
Weyerhaeuser
WY
$15.6B
| $12M | 0.64% |
631,188
+10,992
| +2% | +$257K |
2017 Q2
37 quarters
|
|
50
Lamb Weston
LW
$7.59B
| $11.8M | 0.63% |
283,416
-11,542
| -4% | -$572K |
2024 Q4
7 quarters
|
|
Similar funds
Grandfield & Dodd's Q3 2026 Portfolio in Review
As of Q3 2026, Grandfield & Dodd held 223 positions worth $1.87B, down 1.7% from $1.91B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Grandfield & Dodd's Q3 2026 filing shows 6 new, 53 increased, 70 reduced and 7 closed positions. Its largest new stake was Carlisle Companies: 6,797 shares worth $2.19M. The largest sale was Applied Materials, an estimated $3.25M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Industrials and Healthcare.
- Grandfield & Dodd's largest Q3 2026 buy was Carlisle Companies: 6,797 shares worth $2.19M.
- Grandfield & Dodd added most to Boeing in Q3 2026, an estimated $4.72M increase.
- Grandfield & Dodd's biggest Q3 2026 reduction was Applied Materials, cutting an estimated $3.25M.
- Grandfield & Dodd fully exited Omnicom Group in Q3 2026, selling an estimated $268K.
- Grandfield & Dodd's ten largest holdings make up 39% of its $1.87B portfolio in Q3 2026.
- Grandfield & Dodd opened 6 new positions and closed 7 in Q3 2026.
- Grandfield & Dodd's portfolio value fell 1.7% quarter-over-quarter to $1.87B.
Based on Grandfield & Dodd's 13F filing for Q3 2026, filed 29 Oct 2026.